Saturday, June 23 |
| SPANISH EDUCATIONAL DAY (Programme in the Spanish Language) |
| |
|
| 09.00 – 09.15 |
|
| |
INTRODUCCIÓN |
| |
Dr. E. Muñiz-Diaz (Presidente del Comité Cientific Banc de Sang i
Teixits, Barcelona, Spain) |
| |
|
| 09.00 – 10.45 |
Auditorium A |
| FORO 1: |
Prevención de la aloinmunización materna con gammaglobulina anti-D
en la EHRN |
| Chairs: |
C. Martin-Vega, G. de Souza |
| 1SE-IS-01 |
J. Rodríguez-Villanueva (Complexo Hospitalario de Pontevedra,
Pontevedra, Spain) |
| 1SE-IS-02 |
O. Torres (Hospital Materno Infantil Ramón Sardá, Buenos Aires,
Argentina) |
| |
|
| 10.45 – 11.15 |
|
| |
PAUSA-CAFÉ |
| |
|
| 11.15 – 13.15 |
Auditorium A |
| FORO 2: |
La enfermedad de chagas y otras enfermedades parasitarias |
| Chairs: |
E. Franco, A. del Pozo |
| 1SE-IS-03 |
E. Castro (Centro Transfusión. Cruz Roja Española, Madrid, Spain) |
| 1SE-IS-04 |
G. Smunisch (Pan American Health Organization, Washington DC, USA) |
| |
|
| 12.45 – 13.15 |
Auditorium A |
| CONFERENCIA: |
Uso óptimo de los componentes sanguíneos |
| Chair: |
P. Madoz |
| 1SE-IS-05 |
M. Corral (Hospital Universitario de Salamanca, Salamanca, España) |
| |
|
| 13.15 - 14.45 |
|
| |
COMIDA |
| |
|
| 14.45 – 16.15 |
Auditorium A |
| FORO 3: |
Modelos organizativos en la gestión de la hemoterapia |
| Chairs: |
L. Barbolla, R. Cruz |
| 1SE-IS-06 |
R. Pla (Banc de Sang i Teixits, Barcelona España) |
| 1SE-IS-07 |
C. Martinez (Centro de Sangre Concepcion, Concepcion, Chile) |
| |
|
| 16.15 – 16.45 |
Auditorium A |
| CONFERENCIA: |
La hemovigilancia en el ámbito hospitalario |
| Chair: |
C. Zamora |
| 1SE-IS-08 |
N. Carpio (Hospital Universitario La Fe, Valencia, España) |
| |
|
| 16.45 – 17.15 |
|
| |
PAUSA-CAFÉ |
| |
|
| 17.15 – 18.45 |
Auditorium A |
| FORO 4: |
Controversias en medicina transfusional |
| Chairs: |
R. Mazzara, B. Camacho |
| 1SE-IS-09 |
GEL PLAQUETAR: ¿QUÉ HAY DE CIERTO? |
| |
A. Castrillo (Galician Transfusion Center, Santiago De Compostela,
España, Spain) |
| 1SE-IS-10 |
HEMOCROMATOSIS Y DONACIÓN DE SANGRE |
| |
G. León (Banco Municipal de Sangre Del D.C., Caracas, Venezuela) |
| |
|
| PRE CONGRESS SYMPOSIUM |
| |
|
| 16.30 - 19.00 |
Madrid |
| |
Standardization of Blood Services in the Eastern Mediteranean Region
|
| Chair: |
F. Moftah |
| 16.30 – 16.45 |
|
| |
INTRODUCTION |
| |
F Moftah (Egyptian National Blood Transfusion Service, Cairo, Egypt)
|
| 17.05 – 17.20 |
|
| OPC-01-01 |
NAT UPDATE |
| |
P.N. Lelie (Chiron, Paris, France) |
| 16.45 – 17.05 |
|
| OPC-01-02 |
WHO RECOMMENDATION FOR BASIC REQUIREMENTS OF BTS |
| |
N. Dhingra (WHO, Geneva, Switzerland) |
| 17.20 – 17.35 |
|
| OPC-01-03 |
REASONS FOR AUTOMATION IN BLOOD SERVICES |
| |
J. Georgsen (Funen Transfusion Service, Odense C, Denmark) |
| 17.35 – 17.50 |
|
| OPC-01-04 |
TRAINING AS A PREREQUISITE TO STANDARDIZATION |
| |
B. McClelland (Scottish National Blood Transfusion Serv, Edinburg,
United Kingdom) |
| 17.50 – 18.05 |
|
| OPC-01-05 |
NATIONAL BLOOD STANDARDS, EGYPT EXPERIENCE |
| |
F Moftah (Egyptian National Blood Transfusion Service, Cairo, Egypt)
|
| 18.05 – 18.20 |
|
| OPC-01-06 |
BASIC STANDARDISATION IN RECOURSE LIMITED COUNTRIES |
| |
J.P. Allain (University of Cambridge, Cambridge, United Kingdom) |
| 18.20 – 18.35 |
|
| OPC-01-07 |
TRANSFUSION IN TUNISIA |
| |
S. Hmida (NBTC, Tunis, Tunisia) |
| 18.35 – 18.50 |
|
| OPC-01-08 |
CONVERSIONS OF PAID DONATION TO VNRD, KUWAIT EXPERIENCE |
| |
R. Al-Abdulrazzak (Kuwait) |
| 18.50 – 19.00 |
|
| |
DISCUSSION |
|
| |
|
Sunday, June 24 |
| ISBT EDUCATIONAL DAY (PART 1) |
| |
|
| 08.30 – 12.15 |
Auditorium A |
| Chair: |
E. Seifried, F. Carbonell |
| 08.30 - 08.45 |
|
| |
INTRODUCTION |
| 08.45 - 09.15 |
|
| 2ED-IS-01 |
RATIONAL TESTING FOR TRANSMISSIBLE DISEASES |
| |
S. Wendel (Blood Bank, Sao Paulo, Brasil) |
| 09.15 - 09.45 |
|
| 2ED-IS-02 |
WHERE WILL PATHOGEN INACTIVATION HAVE THE GREATEST IMPACT?
|
| |
T. Hervig (Haukeland University Hospital, Bergen, Norway) |
| 09.45 - 10.15 |
|
| 2ED-IS-03 |
EFFECT OF BACTERIAL TESTING: WHAT RISKS ARE REMAINING? |
| |
E. Beckers (Sanquin Research, Amsterdam, The Netherlands) |
| 10.15 - 10.45 |
|
| |
COFFEE BREAK |
| |
|
| 10.45 - 11.15 |
|
| 2ED-IS-04 |
NEW INSIGHTS IN THE RH SYSTEM: STRUCTURE AND FUNCTION |
| |
N. Avent (University of the West of England, Bristol, United Kingdom)
|
| 11.15 - 11.45 |
|
| 2ED-IS-05 |
PLATELET GENE POLYMORPHISMS AND DISEASE ON BEHALF OF THE
BLOODOMICS CONSORTIUM |
| |
W. Ouwehand (University of Cambridge, Cambridge, United Kingdom) |
| 11.45 - 12.15 |
|
| 2ED-IS-06 |
INSIGHTS AND DIAGNOSTICS OF IMMUNE AND NON-IMMUNE CASES OF
TRALI |
| |
J. Bux (Blood Service "West" of the German Red Cross, Hagen, Germany)
|
| 12.15 - 14.30 |
|
| |
LUNCH BREAK AND SATELLITE SYMPOSIA |
| |
|
| SATELLITE SYMPOSIA |
| |
|
| 12.30 – 14.30 |
Roma |
| Satellite Symposium Organised by Roche |
| SS2: |
Meeting Global Challenges in a NAT Environment |
| Chair: |
J. Saldanha (Roche Molecular Systems, USA) |
| This symposium will cover a variety of topics of interest to those
currently screening blood with nucleic acid amplification techniques or
those considering implementing NAT. Subjects covered will include workflow,
HBV performance in highly endemic areas, and matching NAT coverage to that
currently expected from serology as well as a discussion of future
platforms. |
| 12.30 – 12.45 |
INTRODUCTION |
| 12.45 – 13.10 |
TOWARDS TOTAL AUTOMATION: PREANALYTIC AUTOMATION COUPLED WITH NAT IN A
BLOOD CENTRE IN SPAIN |
| |
M.I. González Fraile (Centro de Hemoterapia de Castilla y León,
Valladolid, Spain) |
| 13.10 – 13.35 |
EPIDEMIOLOGY OF HBV IN ITALY: ARE CURRENT SCREENING STRATEGIES
EFFECTIVE? |
| |
C. Velati (Azienda Ospedaliera della Valtellina e Valchiavenna, Sondrio,
Italy)) |
| 13.35 – 14.00 |
KOUT OF AFRICA: HIV DIVERSITY AND IMPLICATIONS FOR MOLECULAR DIAGNOSIS
|
| |
R. Delgado (Laboratorio de Microbiología Molecular, Madrid, Spain) |
| 14.00 – 14.25 |
THE PLATFORM OF THE FUTURE |
| |
Speaker to be announced |
| |
|
| 12.30 – 14.30 |
Paris |
| Satellite Symposium Organised by Fenwal |
| SS1: |
Are you ready to go mobile with donor side automation? |
| Chair: |
Dr J.L. Bueno (Madrid, Spain) |
| 12.30 – 12.40 |
WELCOME AND INTRODUCTION |
| |
J.L. Bueno (Spanish Red Cross, Madrid, Spain) |
| 12.40 – 13.05 |
IMPACT OF DONOR SIDE AUTOMATION ON MADRID RED CROSS BLOOD CENTRE
EFFICIENCY |
| |
J.L. Bueno (Spanish Red Cross, Madrid, Spain) |
| 13.05 – 13.30 |
NOVEL MOBILE DONATION EXPERIENCE WITH ALYX ON A BUS |
| |
P.O. Forsberg (Bergen, Norway) |
| 13.30 – 13.55 |
IMPLEMENTATION OF MOBILE COLLECTIONS WITH ALYX IN ENGLAND |
| |
C. Falkner (NHS Blood & Transplant, Leicester, United Kingdom) |
| 13.55 – 14.20 |
ROUTINE EXPERIENCE WITH 2RBC AND RBC / PLASMA COLLECTIONS AT LIFESHARE
|
| |
F. Colvin (LifeShare Blood Centers, Shreveport, LA, USA) |
| 14.20 – 14.30 |
ADDITIONAL QUESTIONS AND CONCLUDING REMARKS |
| 14.30 |
ADJOURN |
| |
F. Colvin (LifeShare Blood Centers, Shreveport, LA, USA) |
| |
|
| ISBT EDUCATIONAL DAY (PART 2) |
| |
|
| 14.30 – 17.30 |
Auditorium A |
| Chairs: |
W. Mayr, L. Barbolla |
| 14.30 - 15.00 |
|
| 2ED-IS-07 |
DIAGNOSTIC EVALUATION OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
(FNAITP) |
| |
E. Muñiz-Diaz (Banc de Sang i Teixits, Barcelona, Spain) |
| 15.00 - 15.30 |
|
| 2ED-IS-08 |
SET UP OF TRIALS, REPORTING AND PUBLISHING |
| |
W. Mayr (Medical University Vienna, Wien, Austria) |
| 15.30 – 16.00 |
|
| 2ED-IS-09 |
FETAL GENOTYPING BEYOND THE RH(D) ANTIGEN |
| |
G. Follea (Etablissement Français du Sang PL, Nantes, France) |
| 16.00 - 16.30 |
|
| |
COFFEE BREAK |
| 16.30 - 17.00 |
|
| 2ED-IS-09 |
GETTING THE BEST OUT OF HLA TYPING |
| |
R. Pujol-Borrell (Banc de Sang i Teixits, Badalona, Spain) |
| 17.00 - 17.30 |
|
| 2ED-IS-11 |
DO WE REALLY KNOW THE REAL RISKS OF APHERESIS DONATION? |
| |
J.L. Bueno (Spanish Red Cross, Madrid, Spain) |
| |
|
| 18.00 - 19.00 |
Auditorium A |
| |
OPENING CEREMONY |
| |
|
| 19.00 – 21.00 |
Exhibition Areas |
| |
WELCOME RECEPTION |
|
| |
|
Monday, June 25 |
| SCIENTIFIC PROGRAMME |
| |
|
| 08.30 - 10.30 |
Madrid |
| SESSION 1: |
Prevention of Rh(D) and Non-Rh(D) Immunization |
| Chairs: |
M. de Haas, J. Rodriguez-Villanueva |
| 08.30 - 08.55 |
|
| 3A-S01-1 |
NEW DEVELOPMENTS IN THE BIOLOGICAL ACTIVITY OF MONOCLONAL ANTIBODIES
|
| |
B. Kumpel (Bristol Institute of Transfusion Science, Bristol, United
Kingdom) |
| 08.55 - 09.20 |
|
| 3A-S01-2 |
PREVENTING THE IMMUNE RESPONSE TO RHD BY PEPTIDE TOLERISATION |
| |
S. Urbaniak (University of Aberdeen, Aberdeen, United Kingdom) |
| 09.20 - 09.45 |
|
| 3A-S01-3 |
PREVENTION OF NON-RHD-ANTIBODY MEDIATED HAEMOLYTIC DISEASE IN THE
NEWBORN |
| |
M. de Haas (Sanquin, Amsterdam, The Netherlands) |
| 09.45 - 10.00 |
|
| 3A-S01-4 |
FATAL HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ANTI-JRA ANTIBODY |
| |
T. Peyrard, B.N. Pham, H. Many, S. Fleutiaux, B. Guerin, C. Belcikowski,
P. Rouger, P.Y. Le Pennec (INTS/CNRGS INSERM U665, Paris, France) |
| 10.00 - 10.15 |
|
| 3A-S01-5 |
FAETUS FATAL HAEMOLYTIC DISEASE BY ANTI-JKB, A CASE REPORT |
| |
S. Martinez, I. Luna, F. Arriaga, A. Montava, M. Romero, N. Carpio, M.A.
Sanz (Hospital Universitario La Fe, Valencia, Spain) |
| 10.15 - 10.30 |
#3A-S01-6 INTERACTION BETWEEN THE BAND 3 PROTEIN AND RH COMPLEX IN
SENESCENT ERYTHROCYTES |
| |
L. Racca, A. Ensinck, C. Biondi, A. Rucci, S. García Borrás, C.
Cotorruelo, A. Racca (Universidad Nacional de Rosario, Rosario, Argentina)
|
| |
|
| 08.30 - 10.30 |
Roma |
| SESSION 2: |
The Influence of the Demographic and Epidemiological Changes on Blood
Transfusion |
| Chairs: |
S. Wendel, E. Castro |
| 08.30 - 08.55 |
|
| 3A-S02-1 |
DEMOGRAPHIC FACTORS |
| |
A. Stewart (Scottish Nat. Blood Transfusion Service, Edinburgh, United
Kingdom) |
| 08.55 - 09.20 |
|
| 3A-S02-2 |
INFLUENCE OF THE EPIDEMIOLOGICAL FACTORS ON BLOOD TRANSFUSION |
| |
S. Laperche (Institut National de la Transfusion Sang, Paris, France)
|
| 09.20 - 09.45 |
|
| 3A-S02-3 |
PRECISE MATCH: IMPROVING TRANSFUSION OUTCOMES FOR CHRONICALLY TRANSFUSED
PATIENTS VIA SPECIFIC DONOR RECRUITMENT AND TESTING STRATEGIES IN A LARGE
URBAN BLOOD CENTER |
| |
L. Jones, P. George, J. Valinsky, R. Reiss (New York Blood Center, New
York, USA) |
| 09.45 - 10.00 |
|
| 3A-S02-4 |
THE RISK OF HIV TRANSMISSION BY TRANSFUSION IN ITALY DOESN’T INCREASE
AFTER THE ABOLITION OF BAN ON BLOOD DONATIONS FROM HOMOSEXUAL MEN |
| |
C. Velati, L. Fomiatti, L. Baruffi, L. Romanò, L. Macchi, A. Zanetti
(Sondrio Hospital, Sondrio, Italy) |
| 10.00 - 10.15 |
|
| 3A-S02-5 |
DETECTION OF CHAGAS’ DISEASE ANTIBODIES IN BLOOD DONORS BY TIA
(TRANS-SIALIDASE INHIBITION ASSAY) |
| |
J.L. Blejer, P.A. Sartor, H.J. Salamone, M.S. Leguizamón (Fundación
Favaloro, Buenos Aires, Argentina) |
| 10.15 - 10.30 |
|
| 3A-S02-6 |
SIMULATION MODELING OF TRANSFUSION-TRANSMITTED MALARIA (TTM) RISK IN THE
UNITED STATES |
| |
M. Walderhaug, H. Yang, S. Anderson (U.S. Food and Drug Administration,
Rockville, USA) |
| |
|
| 08.30 - 10.30 |
Auditorium A |
| SESSION 3: |
New Perspectives in Cord Blood Banking |
| Chairs: |
P. Rebulla, J. Garcia |
| 08.30 - 08.55 |
|
| 3A-S03-1 |
LOGISTICAL AND FUNCTIONAL ASPECTS |
| |
J. Garcia (Hospital Duran y Reinals, Barcelona, Spain) |
| 08.55 - 09.20 |
|
| 3A-S03-2 |
ETHICAL AND COST BENEFIT ASPECTS |
| |
S. Querol (The Antony Nolan Trust, Hampstead, London, United Kingdom)
|
| 09.20 - 09.45 |
|
| 3A-S03-3 |
CORD BLOOD BANKING AND ACCREDITATION |
| |
P. Rebulla, L. Lecchi (Foundation Ospedale Maggiore, Milano, Italy) |
| 09.45 - 10.00 |
|
| 3A-S03-4 |
THE PROLIFERATION OF NATURAL KILLER T CELLS IN UMBILICAL
CORD BLOOD OR PERIPERAL BLOOD ,THE DIFFERENT PHENOTYPE BETWEEN THEM AND
THEIR ANTI-TUMOR IMMUNITY |
| |
LY Liu, FHH Fan, YJ Yang, GF Gao (Shanghai, China) |
| 10.00 - 10.15 |
|
| 3A-S03-5 |
UMBILICAL CORD BLOOD TRANSPLANTS IN ADULTS WITH CO-TRANSPLANTATION OF
CD34+ CELLS FROM A SECOND DONOR: METHODOLOGICAL ASPECTS |
| |
M.K. Kwon, J. Anguita, A. Perez Corral, P. Balsalobre, I. Buno, N.
Sanchez Hernandez, D. Serrano, R. Carrion, N. Patrignani, C. Munoz, J.L.
Diez Martin, A. Gomez Pineda (Hospital Gral. Univ. Gregorio Marañon, Madrid,
Spain) |
| 10.15 - 10.30 |
|
| 3A-S03-6 |
PROFILE OF STORED AND TRANSPLANTED CORD BLOOD UNITS FROM SPANISH CORD
BLOOD BANK |
| |
M. Torrabadella, I. Prat, A. Castro, P. Solves, M.J. Rodriguez, J.
Garcia, B.C. Hernandez, A. Castrillo, L. Blanco, L. Larrea, A. Gaya, J.L.
Sánchez-Miret (Barcelona Cord Blood Bank Program, Barcelona, Spain) |
| |
|
| 08.30 - 10.30 |
Paris |
| SESSION 4: |
Therapeutical Apheresis and Immunomodulation |
| Chairs: |
S. Jonsson, J. Muncunill |
| 08.30 - 08.55 |
|
| 3A-S04-1 |
ADSORPTIVE MONOCYTE AND GRANULOCYTE APHERESIS IN THE CHRONIC
INFLAMMATORY ILLNESS: ULCEROUS COLITIS, CHRON DISEASE, RHEUMATOID ARTHRITIS
AND BEHCET SYNDROME |
| |
J. Muñoz, M. Clavo, O. García, D. Reina, A. Vidaller, L.l. Massuet (Banc
de Sang i Teixits, Hospitalet Llobregat, Spain) |
| 08.55 - 09.20 |
|
| 3A-S04-2 |
PHOTOPHERESIS IN GVHD |
| |
C. Perotti (Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy) |
| 09.20 - 09.45 |
|
| 3A-S04-3 |
IMMUNOLOGIC MARKERS OF EFFICACY IN PATIENTS UNDERGOING EXTRACORPOREAL
PHOTOCHEMOTHERAPY |
| |
P Perseghin, E Biagi (Ospedale San Gerardo de' Tintori, Monza, Italy)
|
| 09.45 - 10.00 |
|
| 3A-S04-4 |
THE USE OF A SIMPLIFIED ADSORPTION SYSTEM FOR ABO-INCOMPATIBLE KIDNEY
TRANSPLANTS |
| |
B. Balint, M. Trkuljic, D. Ignjatovic, M. Ostojic (Institute of
Transfusiology, Belgrade, Serbia) |
| 10.00 - 10.15 |
|
| 3A-S04-5 |
AUTOLOGOUS DONATIONS WITH THE ALYX COMPONENT COLLECTION SYSTEM
ASSOCIATED WITH INTRAVENOUS IRON TREATMENT |
| |
M. Menor, M. Ruiz, L. Benito, N. Somolinos, M.C. Monteserin, J.A. Garcia
Vela, F. Oña (Hospital Universitario deGetafe, Getafe - Madrid, Spain) |
| 10.15 - 10.30 |
|
| 3A-S04-6 |
EFFICACY OF A NURSING EDUCATIONAL PROGRAM ON APHERESIS DONATION
PERFORMANCE |
| |
M. Jiménez-Marco, C. Mercant-Gelabert, E. Girona-Llobera, M.
Sedeño-Mombiedro, A. Forteza-Coscojuela (Fundacio Banc de Sang Teixits
Balears, Palma De Mallorca, Spain) |
| |
|
| 10.30 – 11.00 |
|
| |
COFFEE BREAK |
| |
|
| 11.00 - 12.50 |
Auditorium |
| SESSION 5: |
Blood Transfusion Practice (I) |
| Chair: |
B. McClelland, M. Corral |
| 11.00 - 11.25 |
|
| 3A-S05-1 |
WHAT IS THE EVIDENCE FOR CLINICAL EFFECTIVENESS OF BLOOD TRANSFUSION ?
|
| |
E. Briët (Sanquin Blood Supply Foundation, Amsterdam, The Netherlands)
|
| 11.25 - 11.50 |
|
| 3A-S05-2 |
HOW MUCH BLOOD IS THE RIGHT AMOUNT FOR OUR POPULATION: IS THERE A RIGHT
ANSWER? |
| |
B. McClelland (Scottish National Blood Transfusion Serv, Edinburg,
United Kingdom) |
| 11.50 - 12.05 |
|
| 3A-S05-3 |
LOW IMMUNIZATION RATE IN SICKLE CELLS PEDIATRIC PATIENTS |
| |
D. Venturelli, G. Palazzi, L. Bensi, G.B. Ceccherelli, R. Grazian, M. De
Palma (Servizio Medicina Trasfusionale, Modena, Italy) |
| 12.05 - 12.20 |
|
| 3A-S05-4 |
AN EFFECTIVE TRANSFUSION STRATEGY FOR LIMITING THE DONOR EXPOSURE IN
NEWBORNS AND INFANTS BY USING PAEDIATRIC MINI-BAGS |
| |
S. Misso, L. Paesano, B. Feola, M. D'Onofrio, F. Pullano, I. Bernardo,
G. D'Ausanio, E. D'Agostino, G. Fratellanza, A. D'Ambra, A. Minerva (Hospital "S. Anna and S. Sebastiano", Caserta, Italy) |
| 12.20 - 12.35 |
|
| 3A-S05-5 |
EVALUATION OF D+RBCS TRANSFUSION TO D- PATIENTS: TOXICITY AND RESULTS.
|
| |
I. de la Fuente Graciani, J.R. Gonzalez Porras, M.J. Arcos Carmona, C.
Encinas Rodriguez, J. Martin Sanchez, E. Colado Varela, J. Olazabal Herrero,
L. Lopez Corral, J. Alonso Rodriguez, M.P . Conde, M.J. Nieto, M.
Corral, J. San Miguel Izquierdo (Salamanca´s Universitary Hospital,
Salamanca, Spain)
|
| 12.35 - 12.50 |
|
| 3A-S05-6 |
THE EFFECT OF PROTOCOLLED BLOOD TRANSFUSIONS IN RECIPIENTS OF A
SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT |
| |
M.M. Waanders, D.L. Roelen, J.W. de Fijter, M.J.K. Mallat, I.I.N
Doxiadis, A. Brand, F.H.J. Claas (Leiden University Medical Center, Leiden,
The Netherlands) |
| |
|
| 11.00 - 12.50 |
Paris |
| SESSION 6: |
Advances in the Diagnosis and in the Prevention of NAIT |
| Chair: |
C. Kaplan, N. Puig |
| 11.00 - 11.25 |
|
| 3A-S06-1 |
THE ROLE OF THE LOW FREQUENCY ANTIGENS IN NAIT |
| |
C. Kaplan (INTS, Paris, France) |
| 11.25 - 11.50 |
|
| 3A-S06-2 |
SCREENING OF ANTI-HPA-1A IN HPA-1A NEGATIVE MOTHERS |
| |
A. Husebekk, M. Kjaer Killie, B. Skogen, J. Kjeldsen-Kragh (Inst.of Med.
Biolology, Univ. of Tromsø, Tromsø, Norway) |
| 11.50 - 12.05 |
|
| 3A-S06-3 |
A NEW IN VITRO ASSAY DETECTING HPA-1a-SPECIFIC ANTIBODIES BASED ON
PEPTIDE APTAMER TECHNOLOGY |
| |
J. Thibaut, Y. Merieux, D. Rigal, G. Gillet (FOndation pour la Recherche
Diagnostique, Lyon, France) |
| 12.05 - 12.20 |
|
| 3A-S06-4 |
A NEW POLYMORPHISM IN THE PLATELET GLYCOPROTEIN GPIIIA, MAT(A),
ASSOCIATED WITH SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA |
| |
N. Nogues, R. Esteban, M. Gracia, M. Tarrago, M. Ibañez, I. Vinyets, T.
Perez-Castellanos, E. Muñiz-Diaz (Banc de Sang i Teixits, Barcelona, Spain)
|
| 12.20 - 12.35 |
|
| 3A-S06-5 |
HNA-1A, HNA-1B, AND HNA-1C (NA1, NA2 AND SH) FREQUENCIES IN ARGENTINEAN
POPULATION |
| |
D. De La Vega Elena, S. Oyonarte, N. Nogués, P.D. Blanzaco, E. Theiller,
M.A. Raillon, S. Chialina, E. Solis, N. Arancegui, A. Fernández Montoya, V.
Crespo Ferrer, A. Campos Muñoz, E. Muñiz-Diaz (Italian Hospital Garibaldi,
Rosario, Argentina) |
| 12.35 - 12.50 |
| 3A-S06-6 |
PRODUCTION OF THE FIRST HUMAN MONOCLONAL ANTIBODY HIGHLY SPECIFIC FOR
HPA-5B ALLOANTIGEN. APPLICATION FOR THE PHENOTYPING OF PLATELETS. |
| |
D. Rigal, S. Canillas, P. Vigneron, C. Bourgeot, C. Courvoisier, M.
Woicki, J. Bernaud, J.J. Pin, Y. Merieux (EFS de Lyon, Lyon, France)
|
| |
|
| 11.00 - 13.00 |
Roma |
| SESSION 7: |
Promotional Strategies in Voluntary Blood Donation |
| Chairs: |
D. De Coning, J.M. Cárdenas |
| 11.00 - 11.25 |
|
| 3A-S07-1 |
PROMOTION OF BLOOD DONATION: FOLLOWING A PROCESS APPROACH |
| |
J.M. Cárdenas, S. Urcelay (Centro Vasco de Transfusion, San Sebastian,
Spain) |
| 11.25 - 11.50 |
|
| 3A-S07-2 |
MEANS FOR MONITORING PROMOTIONAL ACTIVITIES IN BLOOD DONATION |
| |
N. Mikkelsen (International Federation of Blood Donor, Copenhagen,
Denmark) |
| 11.50 - 12.15 |
|
| 3A-S07-3 |
CLUB 25: A SOCIAL RESPONSE TO BLOOD DONATION IN THE AMERICAS |
| |
N. Garcia de Paredes (Intern.Fed. of Red Cross & Red Crescent, Panama,
Panama) |
| 12.15 - 12.30 |
|
| 3A-S07-4 |
CHARACTERESTICS OF VOLUNTARY NON-REMUNERATED BLOOD DONORS IN PAKISTAN
|
| |
H.A Zaheer, M. Sufyan, K. Hasan (Pakistan Institute of Medical Sciences,
Islamabad, Pakistan) |
| 12.30 - 12.45 |
|
| 3A-S07-5 |
PSYCHO-SOCIAL AND PHYSICAL EFFECTS OF BLOOD DONATION |
| |
H. Javadzadeh Shahshahani, M. Yavari, R. Vafazadeh, M. Attar (Research
center of Iranian BTO, Yazd, Iran) |
| 12.45 - 13.00 |
|
| 3A-S07-6 |
OPTIMAL POLICY FOR USE OF PLATELET CONCENTRATES IN GREECE |
| |
C.P. Politis, P.K. Katsea, C.R. Richardson, A.S. Stayropoulou Gioka
(General Athens Hospital "G. Gennimatas", Athens, Greece) |
| |
|
| 11.00 - 13.00 |
Madrid |
| SESSION 8: |
Blood Transfusion in the European Union |
| Chairs: |
B. Zupanska, M.A. Vesga |
| 11.00 - 11.25 |
|
| 3A-S08-1 |
HOSPITAL BLOOD TRANSFUSION SERVICES IN THE COUNTRIES WHICH JOINED EU IN
THE LAST YEARS - POLAND |
| |
M. Letowska (Institute of Hematology, Warsaw, Poland) |
| 11.25 - 11.50 |
|
| 3A-S08-2 |
HOSPITAL BLOOD TRANSFUSION SERVICES IN THE COUNTRIES WHICH JOINED EU IN
THE LAST YEARS - CZECH REPUBLIC |
| |
I. Turek (Central Military Hospital Prague, Prague, Czech Republic) |
| 11.50 - 12.15 |
|
| 3A-S08-3 |
IMPLEMENTATION OF THE BLOOD DIRECTIVE: WHERE ARE WE? |
| |
T. Bregeon (European Commission, Directorate C, Brussels, Belgium) |
| 12.15 - 12.30 |
|
| 3A-S08-4 |
THE NEW DEAL OF THE ITALIAN BLOOD SYSTEM |
| |
G. Grazzini, A. Ozino Caligaris, G. Aprili, C. Velati, I. Sturvi, D.
Greco (National Blood Centre, Rome, Italy) |
| 12.30 - 12.45 |
|
| 3A-S08-5 |
INFECTIVITY OF ANTI-HBC REACTIVE BLOOD PRODUCTS - CASE CONTROL STUDY
|
| |
M. Schmidt, M.K. Hourfar, E. Seifried (German Red Cross, Frankfurt,
Germany) |
| |
|
| 13.00 - 15.00 |
|
| |
LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS |
| |
|
| SATELLITE SYMPOSIA |
| |
|
| 13.00 – 15.00 |
Auditorium A |
| Satellite Symposium Organised by Chiron |
| SS3: |
Individual Donation (ID)-NAT in the Mediterranean Region – What have
we learned? |
| 13.10 – 13.15 |
WELCOME AND OPENING |
| |
N. Lelie (CHIRON, Suresnes, France) |
| 13,15 – 13.40 |
GREECE: OCCULT HEPATITIS B, NATIONAL SURVEILLANCE, LOW VIRAL LOAD YIELD
CASES |
| |
A. Hatzakis (National Retrovirus Reference Center, Athens, Greece) |
| 13.40 – 14.05 |
ITALY: NAT & SEROLOGY, EPIDEMIOLOGICAL PATTERNS, HIV TRANSMISSIBILITY,
NATIONAL SURVEILLANCE PROGRAMME |
| |
A. Zanetti (Istituto di Virologia – Università degli Studi di Siena,
Milan, Italy) |
| 14.05 – 14.30 |
SPAIN: ANTI-HBC & HBV-DNA, MOLECULAR EPIDEMIOLOGY, OCCULT CARRIER AND
WINDOW PHASE RESIDUAL RISK |
| |
S. Sauleda (Banc de Sang I Texits (BST), Barcelona, Spain) |
| 14.30 – 14.55 |
DISCUSSION: ISBT HBV SAFETY WORKING GROUP, ID-NAT ALGORITHMS, HBV
CONFIRMATION, OCCULT HEPATITIS B AND C |
| |
Moderators : J.P. Allain (University of Cambridge, Cambridge, United
Kingdom) J.I. Esteban (Hospital General Universitari Vall d’Hebron,
Barcelona, Spain) |
| |
|
| 13.00 – 15.00 |
Roma |
| Satellite Symposium Organised by Gambro |
| SS4: |
Whole Blood Processes made simple |
| |
|
| 13.30 – 15.00 |
Madrid |
| Satellite Symposium Organised by Macopharma |
| SS5: |
Innovations in Blood Safety |
| Chairs: |
Dr Emma CASTRO (Centro de Transfusión de Cruz
Roja Española, Madrid, Spain), Prof. Morris BLAJCHMAN (Mc Master University,
Hamilton, Canada), Dr Wolfram H. WALKER (MacoPharma, Langen, Germany) |
| |
PLASMA SAFETY: |
| |
Use and results of Methlylene Blue virus inactivated
Plasma |
| |
Dr Luis LARREA, Centro de Transfusión de la Comunidad
Valenciana, Valencia, Spain |
| |
PLATELETS SAFETY: |
| |
The THERAFLEX UV Platelets procedure for Pathogen Inactivation of Platelet Concentrates |
| |
Dr Harald MOHR, DRK NSTOB, Springe, Germany |
| |
Preliminary data on UVC-treated platelets |
| |
Prof Morris BLAJCHMAN, Mc Master University, Hamilton,
Canada |
| |
RED CELLS SAFETY: |
| |
Pathogen Reduction in Red Cell Concentrate: Prion removal filter |
| |
Mr Mike WILTSCHIRE, CDL, NBS Brentwood, England |
| |
|
| SCIENTIFIC PROGRAMME |
| |
|
| 15.00 - 16.30 |
Auditorium A |
| |
PLENARY SESSION 1 |
| Chairs: |
P.F.W. Strengers, E. Muñiz-Diaz |
| 15.00 - 15.45 |
|
| 3B-PL1-1 |
HEPATITIS B AND BLOOD TRANSFUSION |
| |
W.K. Roth (GFE Blut mbH, Frankfurt Am Main, Germany) |
| 15.45 - 16.30 |
|
| 3B-PL1-2 |
THE ECONOMICS OF BLOOD TRANSFUSION IN THE XXI CENTURY |
| |
A. Pereira (Service of Hemotherapy and Hemostasis, Hôpital Clinic,
Barcelona, Spain) |
| |
|
| 16.30 – 17.00 |
|
| |
COFFEE BREAK |
| |
|
| 17.00 - 18.35 |
Paris |
| SESSION 9: |
History of Blood Transfusion |
| Chairs: |
M. Bayik, C. Martin-Vega |
| 17.00 - 17.25 |
|
| 3A-S09-1 |
THE CONTRIBUTION OF DR. DURAN-JORDA TO THE ADVANCE AND DEVELOPMENT OF
THE EUROPEAN BLOOD TRANSFUSION |
| |
J.R. Grifols (Banc de Sang i Teixits, Badalona, Spain) |
| 17.25 - 17.50 |
|
| 3A-S09-2 |
THE ROLE OF THE COUNCIL OF EUROPE IN THE DEVELOPMENT OF THE EUROPEAN
BLOOD TRANSFUSION |
| |
W.A. van Aken (Amstelveen, The Netherlands) |
| 17.50 - 18.05 |
|
| 3A-S09-3 |
WARM STORAGE OF WHOLE BLOOD FOR 72 HOURS |
| |
R. Hess (University of Maryland, Baltimore, United States of America)
|
| 18.05 - 18.20 |
|
| 3A-S09-4 |
DESIGN OF A MODERN BLOOD COMPONENT MANUFACTURING FACILITY |
| |
D. Edmondson, N.P. Tandy, G.S. Nicholson, M. Ashford (National Blood
Service, Bristol, United Kingdom) |
| 18.20 - 18.35 |
|
| 3A-S09-5 |
HISTORY OF BLOOD TRANSFUSION IN THE REPUBLIC OF SERBIA |
| |
N. Nedeljkovic (National Blood Transfusion Institute, Belgrade, Serbia)
|
| |
|
| 17.00 - 18.35 |
Madrid |
| SESSION 10: |
Cost/Benefit of the Quality System in the European blood transfusion
|
| Chairs: |
E. Seifried, M. Perez-Vaquero |
| 17.00 - 17.25 |
|
| 3A-S10-1 |
THE DIFFERENT TOOLS IN THE QUALITY MANAGEMENT |
| |
N. Grunnet (Aarhus University Hospital, Skejby, Aarhus N, Denmark) |
| 17.25 - 17.50 |
|
| 3A-S10-2 |
DO CERTIFICATION AND ACCREDITATION IMPROVE QUALITY OF TRANSFUSION
MEDICINE? |
| |
C. Seidl (Inst for Transf. Med & Immunohematology, Frankfurt Am Main,
Germany) |
| 17.50 - 18.05 |
|
| 3A-S10-3 |
THE SPANISH BLOOD TRANSFUSION ACCREDITATION COMMITTEE EXPERIENCE: A
REVIEW OF THE MOST FREQUENT NONCONFORMANCES, 2004-2006. |
| |
M. Ruiz Romero, J.L. Arroyo Rodríguez, L. Barea García, J. Candela
García, A. Castrillo Fernández, J. García Gala, L. Larrea González, M. López
Soques, F. Monsalve Gil-Fournier, I. Ortiz de Salazar, P. Rodríguez Vicente,
M. Torrabadella de Reynoso, J. Rodríguez Villanueva (Spanish Blood
Transfusion Accreditation, Barcelona, Spain) |
| 18.05 - 18.20 |
|
| 3A-S10-4 |
FROM IN HOUSE MINI-POOL NAT TO CE ACCREDITED IVD – IMPROVEMENT IN BLOOD
SAFETY |
| |
M. Schmidt, M.K. Hourfar, W. Sireis, S. Findhammer, E. Schellenberg, U.
Mayr-Wohlfart, H. Schrezenmeier, J. Mytilineos, K. Gubbe, A. Karl, E.
Seifried (German Red Cross, Frankfurt, Germany) |
| 18.20 - 18.35 |
|
| 3A-S10-5 |
MONITORING AND IMPROVEMENT OF DOCUMENTATION REQUIREMENTS FOR BLOOD
DELIVERING AND TRANSFUSION PROCESS. |
| |
J. Rivera, A. Cascales, F. Ferrer, A. Periago, A. Garcia, A. Rodriguez,
A. Lopez, V. Vicente (Centro Regional de Hemodonacion, Murcia, Spain)
|
| |
|
| 17.00 - 18.35 |
Roma |
| SESSION 11: |
New Technologies in Blood Transfusion |
| Chairs: |
G. Daniels, E. Aranburu |
| 17.00 - 17.25 |
|
| 3A-S11-1 |
MICROARRAY TECHNOLOGY AND ITS APPLICATION TO BLOOD GROUPING |
| |
N. Nogues (Banc de Sang i Teixits, Barcelona, Spain) |
| 17.25 - 17.50 |
|
| 3A-S11-2 |
MOLECULAR ANALYSIS OF RH(D) NEGATIVE DONORS: COST EFFICIENCY |
| |
W. Flegel (Institut fur Klinische Transfusionsmedizin und Immungenetik,
Ulm, Germany) |
| 17.50 - 18.05 |
|
| 3A-S11-3 |
MOLECULAR GENETIC INVESTIGATION OF BLOOD DONORS WITH WEAK RHE EXPRESSION
REVEALS A BROAD SPECTRUM OF DIVERSE POLYMORPHISMS. |
| |
A. Doescher, E.K. Petershofen, F.F. Wagner (Red Cross Blood Transfusion
Service, Oldenburg, Germany) |
| 18.05 - 18.20 |
|
| 3A-S11-4 |
MASS SCREENING FOR RHD GENE FRAGMENTS IN RHD NEGATIVE DONORS BY MINIPOOL
TESTING SYSTEM USING REAL TIME PCR TECHNOLOGY |
| |
A. Orzinska, M. Pelc-Klopotowska, B. Michalewska, A. Walaszczyk, G.
Liszewski, B. Zupanska, E. Brojer (Institute of Haematology and Transfusion,
Warsaw, Poland) |
| 18.20 - 18.35 |
|
| 3A-S11-5 |
WEAK BLOOD GROUP B PHENOTYPES CAUSED BY VARIATIONS IN THE CBF-NFY
ENHANCER REGION OF THE ABO GENE |
| |
A. Seltsam, F.F. Wagner, D. Grueger, C. Das Gupta, C. Bade-Doeding, R.
Blasczyk (Hannover Medical School, Hannover, Germany) |
| |
|
| 17.00 - 18.35 |
Auditorium A |
| SESSION 12: |
Blood Transfusion Practice (II) |
| Chairs: |
D. Teo, F. Gilsanz |
| 17.00 - 17.25 |
|
| 3A-S12-1 |
TREATMENT OF MASSIVELY BLEEDING PATIENTS - TIME TO CHANGE? |
| |
I. Johansson, J. Stensballe, M.B. Hansen, L. Jørgensen, N.H. Secher (HS
Blood bank, Rigshospitalet, Copenhagen, Denmark) |
| 17.25 - 17.50 |
|
| 3A-S12-2 |
MASSIVE BLOOD TRANSFUSION AND COAGULOPATHY: PATHOPHYSIOLOGY AND CLINICAL
IMPLICATIONS |
| |
Speaker to be announced |
| |
|
| 17.50 - 18.05 |
|
| 3A-S12-3 |
EFFECT OF PLATELET ACTIVATION ON BLEEDING AND TRANSFUSION RATES IN
PATIENTS UNDERGOING HIGH RISK CARDIAC SURGERY |
| |
R. Radovancevic, R. Radovancevic, A. Bracey, N. Matijevic, S. Carranza,
I. Gregoric, O. Frazier (Texas Heart Institute, Houston, USA) |
| 18.05 - 18.20 |
|
| 3A-S12-4 |
CONTINUING EDUCATION IN TRANSFUSION MEDICINE: 10 YEARS OF EXPERIENCE IN
THE UNIVERSITY HOSPITAL OF SALAMANCA |
| |
J. Martin Sanchez, M.J. Rodriguez Dominguez, J.R. Gonzalez Porras, J.J.
Mateos Mazon, O. Lopez Villar, E. Colador Varela, I. De La Fuente Graciani,
M.J. Arcos Carmona, C. Encinas Rodriguez, M.J. Nieto Hernandez, M.
Corral Alonso (Hospital Universitario de Salamanca, Salamanca, Spain) |
| 18.20 - 18.35 |
|
| 3A-S12-5 |
PLATELET TRANSFUSION CLINICALLY APPROPRIATE IN NEONATAL INTENSIVE CARE
UNIT |
| |
S. Misso, B. Feola, L. Paesano, G. Fratellanza, M. D'Onofrio, E.
D'Agostino, F. Pullano, I. Bernardo, G. D'Ausanio, F. Migliaro, A.
Fratellanza, A. Minerva (Hospital "S. Anna and S. Sebastiano", Caserta, Italy) |
|
| |
|
Tuesday, June 26 |
| SCIENTIFIC PROGRAMME |
| |
|
| 08.30 - 10.20 |
Paris |
| SESSION 13: |
Haemovigilance: Much More Than a Register |
| Chairs: |
P. Robillard, M.T. Jimenez |
| 08.30 - 08.43 |
|
| 4A-S13-1 |
IMPACT OF THE CORRECTIVE AND PREVENTIVE MEASURES IMPLEMENTED IN
DIFFERENT COUNTRIES - CANADA |
| |
P. Robillard (Quebec Public Health Institute, Montreal (qc), Canada)
|
| 08.43 - 08.56 |
|
| 4A-S13-2 |
IMPACT OF THE CORRECTIVE AND PREVENTIVE MEASURES IMPLEMENTED IN
DIFFERENT COUNTRIES - UNITED KINGDOM |
| |
D. Stainsby (Serious Hazards of Transfusion, Newcastle Upon Tyne, United
Kingdom) |
| 08.56 - 09.09 |
|
| 4A-S13-3 |
IMPACT OF THE CORRECTIVE AND PREVENTIVE MEASURES IMPLEMENTED IN
DIFFERENT COUNTRIES - FRANCE |
| |
Ph. Renaudier (Hopital de la Croix Rousse, Lyon, France) |
| |
|
| 09.09 - 09.49 |
|
| 4A-S13-4 |
RAPID ALERT: HOW CAN ITS UTILITY BE IMPROVED? |
| |
J.C. Faber (Luxembourg Red Cross, Luxembourg, Luxembourg) |
| 09.50 - 10.05 |
|
| 4A-S13-5 |
HEMOVIGILANCE FOR TRANSFUSION OF INTERCEPTTM PLATELETS IN ROUTINE
THERAPEUTIC USE: EXPERIENCE IN ÉTABLISSEMENT FRANÇAIS DU SANG (EFS) BLOOD CENTERS |
| |
O. Garraud, P. Fabrigli, R. Tardivel, H. Gouezec, C. Waller, I. Mendel,
J.P. Raidot, G. Kandel, H. Isola, J.P. Cazenave (EFS - Auvergne Loire, Saint
Etienne, France) |
| 10.05 - 10.20 |
|
| 4A-S13-6 |
PREVENTION OF IMMUNE TRALI BY SCREENING FOR LEUKOCYTE ANTIBODIES |
| |
A. Reil, D. Manke, J. Bux (German Red Cross Blood Service West, Hagen,
Germany |
| |
|
| 08.30 - 10.30 |
Auditorium A |
| SESSION 14: |
Recipient Immune Status and Blood Transfusion in different stages |
| Chairs: |
J.P. Allain, S. Oyonarte |
| 08.30 - 08.55 |
| 4A-S14-1 |
IMPACT OF RECIPIENT IMMUNE STATUS AND INFECTION RISKS OF TRANSFUSION
|
| |
H.W. Reesink (Sanquin Blood Bank North-West Region, Amsterdam, The
Netherlands) |
| 08.55 - 09.20 |
| 4A-S14-2 |
DIFFERENTIATING TRANSFUSION-TRANSMITTED INFECTION AND REACTIVATION |
| |
J.P. Allain (University of Cambridge, Cambridge, United Kingdom) |
| 09.20 - 09.45 |
| 4A-S14-3 |
EFFECT OF RECIPIENT IMMUNE STATUS ON THE DEVELOPMENT, PERSISTENCE AND
CLINICAL CONSEQUENCES OF TRANSFUSION-RELATED MICROCHIMERISM |
| |
|
| |
M. Busch (Blood Systems Research Institute, San Francisco, USA) |
| 09.45 - 10.00 |
| 4A-S14-4 |
RISK OF HBV-DNA-POSITIVE, HBSAG-NEGATIVE DONATIONS REDUCED BY ANTI-HBC
TESTING: THE CANADIAN BLOOD SERVICES EXPERIENCE |
| |
F. O'Brien, M.A. Fearon, Q. Yi, W. Fan, V. Scalia, E. Zuber, E.C.
Vamvakas (Canadian Blood Services, Ottawa, Canada) |
| 10.00 - 10.15 |
|
| 4A-S14-5 5 |
YEARS BACTERIAL SCREENING OF PC IN THE NETHERLANDS |
| |
D. de Korte, J. Curvers, E.A.M. Beckers, J.H. Marcelis (Sanquin
Research, Amsterdam, The Netherlands) |
| 10.15 - 10.30 |
|
| 4A-S14-6 |
IMPACT OF INDIVIDUAL DONATION (ID)-NAT ON THE RISK OF TRANSFUSION
TRANSMITTED HIV INFECTIONS IN SOUTH AFRICA |
| |
W. Sykes, R. Reddy, S. Gulube, M. Vermeulen, R. Swanevelder, E. Kuun, N.
Lelie, R. Crookes (SANBS, Roodepoort, South Africa) |
| |
|
| 08.30 - 10.30 |
Madrid |
| SESSION 15: |
A Critical Approach to Evidence-based Transfusion |
| Chairs: |
M. Olsson, A. Fernandez-Montoya |
| 08.30 - 08.55 |
| 4A-S15-1 |
THE STRENGTHS AND WEAKNESSES OF THE EVIDENCE BASE FOR IMPROVING
TRANSFUSION PRACTICE. |
| |
M.F. Murphy, S. Brunskill, S. Stanworth, C. Doree, P.A. Robeda, C. Hyde
(National Blood Service, Oxford, United Kingdom) |
| 08.55 - 09.20 |
|
| 4A-S15-2 |
IMPACT OF EVIDENCE-BASED TRANSFUSION IN THE TRANSFUSION PRACTICE AND
POTENTIAL IMPACT ON LITIGATIONS |
| |
K. Sazama (The University of TX, MD Anderson Cancer Cente, Houston, USA)
|
| 09.20 - 09.45 |
|
| 4A-S15-3 |
CRITICAL ANALYSES OF THE TOP TEN ARTICLES THAT MOST INFLUENCED BLOOD
TRANSFUSION IN RECENT YEARS |
| |
M. Blajchmann (McMaster University, Hamilton, Canada) |
| 09.45 - 10.00 |
| 4A-S15-4 |
DETECTION OF MICROCHIMERISM IN NORMAL BLOOD DONORS |
| |
T.H.L. Lee, G. Utter, W. Reed, L. Wen, D. Chafets, L. Montalvo, M. Busch
(Blood Systems Research Institute, San Francisco, United States of America)
|
| 10.00 - 10.15 |
|
| 4A-S15-5 |
RED CELL TRANSFUSION FOR IRON DEFICIENCY ANAEMIA |
| |
E. Grey, J. Finlayson (PathWest Laboratory Medicine WA, Perth,
Australia) |
| 10.15 - 10.30 |
| 4A-S15-6 |
ASSOCIATION OF ANTI-LEUKOCYTE ANTIBODIES WITH TRALI PARTLY EXPLAINED BY
PUBLICATION BIAS |
| |
R. Middelburg, E. Briët, J.G. Van der Bom (Leiden University Medical
Center, Leiden, The Netherlands) |
| |
|
| 08.30 - 10.30 |
Roma |
| SESSION 16: |
Platelet Components and Platelet Transfusion |
| Chairs: |
N. Kalmin, M. Lozano |
| 08.30 - 08.55 |
| 4A-S16-1 |
PLATELET COMPONENTS, TODAY |
| |
M. Lozano (Hospital Clinic Provincial, Barcelona, Spain) |
| 08.55 - 09.20 |
| 4A-S16-2 |
CONTROVERSY CONCERNING PLATELET DOSES |
| |
N. Heddle (McMaster University, Hamilton, Canada) |
| 09.20 - 09.45 |
| 4A-S16-3 |
QUALITY OF PLATELET CONCENTRATES FROM POOLED BUFFY-COATS MADE OF FRESH
WHOLE BLOOD PROCESSED ON ATREUS 2C+ SYSTEM |
| |
P. Sandgren, H. Gulliksson, M. Callaert (Karolinska University Hospital,
Stockholm, Sweden) |
| 09.45 - 10.00 |
|
| 4A-S16-4 |
ALTERATION OF PLATELET PROTEINS DURING STORAGE ASSESSED BY PROTEOMICS:
EVIDENCE OF ONGOING PROTEIN TRANSLATION OVER THE STORAGE PERIOD |
| |
V. Devine, N. Thon, P. Schubert, K. Serrano, J. Kast (Canadian Blood
Services, Vancouver, Canada) |
| 10.00 - 10.15 |
|
| 4A-S16-5 |
PLATELETS STORED AT 4°C, AN EVALUATION OF PLATELETS IN SSP+ ADDITIVE
SOLUTION |
| |
P.F. van der Meer, M. Eijzenga, R.N.I. Pietersz (Sanquin Blood Bank
North West Region, Amsterdam, The Netherlands) |
| 10.15 - 10.30 |
|
| 4A-S16-6 |
POST AUTHORIZATION SURVEILLANCE OF PLATELET CONCENTRATES AFTER
TRANSFUSION |
| |
M.J. Dijkstra-Tiekstra, E. Djasmadi, J. de Wildt-Eggen (Sanquin Blood
Bank North East Region, Groningen, The Netherlands) |
| |
|
| 10.30 – 11.00 |
|
| |
COFFEE BREAK |
| |
|
| 11.00 - 12.30 |
Auditorium A |
| |
ISBT GENERAL ASSEMBLY |
| |
|
| 11.00 - 12.30 |
Roma |
| F1: |
FORO DE PROMOCION DE LA SETS |
| |
Promoción integral sostenible: formar e informar |
| |
VOLUNTARIADO Y DONANTES |
| |
V. Calluo and A.V Sánchez (BST-Hospital Joan XXIII, Tarragona, Espana)
|
| |
POBLACIÓN GENERAL, INSTITUCIONES Y MEDIOS DE COMUNICACIÓN |
| |
M Sala (Gerente de la Hermandad de donantes de Mallorca, Espana) |
| |
EDUCACIÓN Y EDUCADORES (PROFESORADO Y PERSONAL SANITARIO) |
| |
S Urcelay (Centro Vasco de transfusión y tejidos humanos de Guipúzcoa,
Espana). |
| |
|
| 11.00 - 12.30 |
Paris |
| F2: |
FORO DE ENFERMERIA DE LA SETS |
| |
Dimensiones de la práctica de enfermería en la Seguridad transfusional.
El valor del registro |
| |
Speakers: |
| |
P. de la Peña (Enfermera responsable de Promoción del CRTS de Madrid,
Espana) |
| |
M. Fernández (Enfermera del área de extracciones, Oviedo, Espana) |
| |
A. Mingo (Supervisor de Enfermería. BST-Hospital J Trueta, Gerona,
Espana) |
| |
|
| SATELLITE SYMPOSIA |
| |
|
| 12.30 – 14.30 |
Rome |
| Satellite Symposium Organised by Contoltechnica |
| SS6: |
Advanced Blood Management: The Hemosafe® System |
| Chair: |
to be confirmed |
| 12.30 – 13.00 |
SMART BLOOD BANKS AND REMOTE BLOOD MANAGEMENT |
| |
P.P. Pagliaro (Blood Center Director, Mantova, Italy) |
| 13.00 – 13.10 |
THE “HEMOSAFE®” SYSTEM – GENERAL REMARKS |
| |
L.M.Cappelletti (Angelantoni Industry, Massa Martana, Italy) |
| 13.10 – 13.50 |
THE “HEMOSAFE®” SYSTEM– PRACTICAL APPLICATIONS |
| |
S. Ventura (Angelantoni Industry, Massa Martana, Italy) |
| 13.50 – 14.15 |
DISCUSSION |
| 14.15 – 14.30 |
LUNCH BOXES |
| |
|
| 12.30 – 14.30 |
Madrid |
| Satellite Symposium Organised by Octapharma |
| SS7: |
360º around solvent-detergent plasma |
| The symposium will review the solvent-detergent plasma from all angles.
It will also show data on haemovigilance as well as covering the topic of
adverse events related to plasma transfusion with a special focus on TRALI.
|
| |
|
| 12.30 – 14.30 |
Paris |
| Satellite Symposium Organised by Cerus |
| SS8: |
A Single Pathogen Inactivation System for Two Blood Components: INTERCEPT Blood System for Platelets and Plasma |
| Chair: |
J.P. AuBuchon (United States of America) |
| |
INTRODUCTION |
| |
J.P. AuBuchon (Dartmouth-Hitchcock Medical Center, Lebanon, Nh, United
States of America) |
| |
IMPLEMENTATION IN A HIGH VOLUME CENTER: IN VITRO CHARACTERISTICS OF
INTERCEPT PLASMA |
| |
R. Henschler (Germany) |
| |
TWO PATHOGEN INACTIVATED BLOOD PRODUCTS FROM ONE DONATION - TREATMENT OF
PLATELETS AND CONCURRENT PLASMA |
| |
E. Castro (Centro Transfusión. Cruz Roja Española, Madrid, Spain) |
| |
SYNERGY OF INTERCEPT PLATELETS AND PLASMA IN ROUTINE USE |
| |
J-P. Cazenave (Établissement Français du Sang-Alsace, Strasbourg,
France) |
| |
|
| 14.30 - 15.15 |
Auditorium A |
| PLENARY SESSION 2: |
Lección Professor Ricardo Castillo |
| Chairs: |
E. Muniz-Diaz, J.F. Chapman |
| 14.30 - 15.15 |
|
| 4B-PL2-1 |
GOODBYE TO AGGLUTINATION? |
| |
D. Anstee (Bristol Institute for Transfusion Scienc, Bristol, United
Kingdom) |
| |
|
| 15.15 - 15.45 |
|
| |
COFFEE BREAK |
| |
|
| SCIENTIFIC PROGRAMME |
| |
|
| 15.45 - 17.20 |
Madrid |
| SESSION 17: |
Thrombotic Thrombocytopenic Purpurra (TTP) |
| Chairs: |
P. Hôcker, J.L. Bueno |
| 15.45 - 16.10 |
| 4C-S17-1 |
TTP AND PREGNANCY |
| |
M. Scully (Haemostasis Research Unit, London, United Kingdom) |
| 16.10 - 16.35 |
| 4C-S17-2 |
THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP): IS ANY PLASMA USEFUL TO TREAT
THE TTP? |
| |
J. Muncunill (IB Salut, Servei d'Hematologia i Hemoter, Palma De
Mallorca, Spain) |
| 16.35 - 16.50 |
| 4C-S17-3 |
LACK OF EFFECTIVENESS OF PLASMA-EXCHANGE IN CANCER-RELATED THROMBOTIC
THROMBOCYTOPENIC PURPURA |
| |
M. Bianchi, I. Rago, N. Piccirillo, F. Sorà, M. Maresca, R. Putzulu, G.
Zini, G. D'Onofrio, G. Giuseppe (Catholic University of Sacred Heart, Rome,
Italy) |
| 16.50 - 17.05 |
|
| 4C-S17-4 |
METHYLENE BLUE PHOTOINACTIVATED PLASMA (MBPIP) VS FRESH FROZEN PLASMA
(FFP) IN THE TREATMENT OF IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA
(TTP): A MULTICENTRIC PROSPECTIVE-COHORT STUDY |
| |
J. del Rio-Garma, A. Alvarez-Larran, C. Martinez, J. de la Rubia, C.
Zamora, J. Muncunill, M. Corral, A. Garcia-Noblejas, J. Mateo, J. Muñoz, E.
Gomez-Arteta, M. Pujol, J.M. Jimenez, P. Rodriguez-Vicente, E. Contreras, C.
Arbona, A. Pereira (Complejo Hospitalario de Orense, Orense, Spain) |
| 17.05 - 17.20 |
|
| 4C-S17-5 |
RITUXIMAB FOR TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING
THROMBOTIC THROMBOCYTOPENIC PURPURA. |
| |
M. Romero, J. De la Rubia, A. Montava, I. Luna, S. Martínez, N. Carpio,
M.A. Sanz (Hospital Universitario La Fe, Valencia, Spain) |
| |
|
| 15.45 - 17.20 |
Roma |
| SESSION 18: |
Information to Transfusion Medicine |
| Chairs: |
C. Munk, L. Larrea |
| 15.45 - 16.10 |
| 4C-S18-1 |
HOW TO DEAL WITH INFORMATION IN TRANSFUSION MEDICINE? |
| |
C. Munk (Service Régional Vaudois de Transfusion, Lausanne, Switzerland)
|
| 16.10 - 16.35 |
| 4C-S18-2 |
DATA INTERCHANGE AND RELATED TECHNOLOGIES IN TRANSFUSION MEDICINE |
| |
P. Bruce (Finnish Red Cross Blood Service, Helsinki, Finland) |
| 16.35 - 16.50 |
| 4C-S18-3 |
MANAGEMENT OF A HOSPITAL BLOOD BANK USING RADIO-FREQUENCE IDENTIFICATION
(RFID) |
| |
G. Follea, G. Bourreille, F. Dussaux, C. David, F.-L. Monge, C Ledoux,
J.-C. Mongrenier (Etablissement Français du Sang PL, Nantes, France) |
| 16.50 - 17.05 |
|
| 4C-S18-4 |
USING GLOBAL POSITIONING SYSTEMS TO ENHANCE PRODUCTIVITY IN A BLOOD
CENTER |
| |
N.D. Kalmin, R. Garcia, K. Myers (South Texas Blood & Tissue, San
Antonio, USA) |
| 17.05 - 17.20 |
|
| 4C-S18-5 |
FULL UNIT TRACKING 'FROM VEIN TO VEIN'. THE EXPERIENCE OF THE CENTRAL
HOSPITAL IN CIUDAD REAL (SPAIN) |
| |
P. Pereda Gomez, J.M. De Luis Gonzalez, A. Martinez Santaolalla (Centro
de Innovacion en Tecnologias, Valladolid, Spain) |
| |
|
| 15.45 - 17.20 |
Auditorium A |
| SESSION 19: |
Errors in Blood Component Administration: How to Prevent Them? |
| Chairs: |
R. de Vries, N. Carpio |
| 15.45 - 16.10 |
| 4C-S19-1 |
ERRARE HUMANUM EST...BUT IT IS ALSO HUMAN TO PREVENT ERRORS |
| |
D. Cummins (Royal Bromton and Harefield Hospital NHS Trust, Harefield,
Middlesex, United Kingdom) |
| 16.10 - 16.35 |
|
| 4C-S19-2 |
PROCESS CONTROLS TO AVERT MISTRANSFUSION |
| |
J.P. AuBuchon (Dartmouth-Hitchcock Medical Center, Lebanon, Nh, USA)
|
| 16.35 - 16.50 |
| 4C-S19-3 |
HEMOLYTIC TRANSFUSION REACTIONS FOLLOWING ADMINISTRATION OF INTRAVENOUS
GAMMAGLOBULIN |
| |
Z. Daw, R. Padmore, M. Tokessy, N. Cober, D. Neurath, D. Desjardins, B.
Olberg, A. Tinmouth, A. Giulivi (Ottawa Hospital, Ottawa, Canada) |
| 16.50 - 17.05 |
|
| 4C-S19-4 |
ADDITIONAL BENEFITS OF HAEMOVIGILANCE: CAN HAEMOVIGILANCE SYSTEMS DETECT
GOOD AND 'EXPECTED' EFFECTS TOO? |
| |
M. Lopez Soques, M. Bosch, A. Orfila, M. Carrasco, C. Besses, J. Cid,
M.C. Raya, C. Basil, J. Garcia Alvarez, P. Carrasco, I. Campodarve, C.
Solis, A. DeArriba (Hospital del Mar, Barcelona, Spain) |
| 17.05 - 17.20 |
|
| 4C-S19-5 |
QUALITY MANAGEMENT IN IMMUNOHEMATOLOGY |
| |
G.M.B.L. Leal, L.Y. Noguchi, M.C.C. Poli, M.M.M. Lemos, R.T. Scuotto, R.
Colella (Hospital A.C. Camargo, Sao Paulo, Brazil) |
| |
|
| 17.20 - 19.00 |
Roma |
| |
ASAMBLEA GENERAL SETS |
|
| |
|
Wednesday, June 27 |
| SCIENTIFIC PROGRAMME |
| |
|
| 08.30 - 10.30 |
Roma |
| SESSION 20: |
Rationalisation of the Use of Allogeneic Blood Transfusion and its
Alternatives |
| Chairs: |
M. Contreras, J. Garcia-Erce |
| 08.30 - 08.55 |
| 5A-S20-1 |
RATIONALISATION OF BLOOD USE: THE UK'S EXPERIENCE |
| |
M. Contreras (National Blood Service, London, United Kingdom) |
| 08.55 - 09.20 |
| 5A-S20-2 |
PHARMACOLOGICAL MANAGEMENT OF PERIOPERATIVE ANAEMIA: OUR EXPERIENCE IN
ORTHOPAEDIC SURGERY |
| |
M. Muñoz, J.A. García-Erce, J. Cuenca, E. Bisbe (School of Medicine,
University of Málaga, Málaga, Spain) |
| 09.20 - 09.45 |
|
| 5A-S20-3 |
PERIOPERATIVE BLOOD CONSERVATION: THE ROLE OF CELL SALVAGE |
| |
D. Thomas (Swansea NHS Trust, Swansea, United Kingdom) |
| 09.45 - 10.00 |
|
| 5A-S20-4 |
DOES PRE-OPERATIVE CORRECTION OF ANAEMIA REDUCE THE NEED OF RED CELL
TRANSFUSION IN PATIENTS UNDERGOING MAJOR JOINT SURGERY? |
| |
E. Saleh, T.S. Walsh, D.B.L. McClelland, D. Semple (Edinburgh
University, Edinburgh, United Kingdom) |
| 10.00 - 10.15 |
#5A-S20-5 ALLOGENEIC BLOOD TRANSFUSION SAVING PROGRAM BASED ON SELECTED
PRE-SURGICAL AUTOLOGOUS BLOOD COLLECTION OR STIMULATION OF ERYTHROPOIESIS
FOR PATIENTS UNDERGOING SPINE SURGERY |
| |
F. Moscardó, T. Bas, S. Martínez, M. Romero, J. Sanz, M.L. Paciello, F.
Arriaga, J. De la Rubia, M.A. Sanz, N. Carpio (Hospital Universitario La Fe,
Valencia, Spain) |
| 10.15 - 10.30 |
| 5A-S20-6 |
DISASTER-PREPAREDNESS PLAN AT SAINT-GEORGE UNIVERSITY MEDICAL CENTER
DURING THE SUMMER 2006 WAR AND BLOCKADE ON LEBANON |
| |
H.R. Samaha, N.A. Irani-Hakimeh, I.P. Hajj (Saint GeorgeUniversity
Medical Center, Beirut, Lebanon) |
| |
|
| 08.30 - 10.30 |
Madrid |
| SESSION 21: |
Cellular Therapy |
| Chairs: |
W.R. Mayr, M. Lamana |
| 08.30 - 08.55 |
| 5A-S21-1 |
POTENTIAL APPLICATIONS OF DENDRITIC CELLS |
| |
J. de Vries (Radboud University Nijmegen Medical Cent, Nijmegen, The
Netherlands) |
| 08.55 - 09.20 |
| 5A-S21-2 |
PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) BY ADIPOSE TISSUE-DERIVED
MESENCHYMAL STEM CELLS (AD-MSCSS) IN ALLOGENEIC BONE MARROW TRANSPLANTS |
| |
M. Lamana, R. Yañez, J. García Castro, M. Ramírez, J. Bueren (CIEMAT &
Hospital Niño Jesús, Madrid, Spain) |
| 09.20 - 09.45 |
|
| 5A-S21-3 |
STEM CELL PLASTICITY AND REGULATION |
| |
C. Verfaille (KU Leuven Stamcelinstituut, Leuven, Belgium) |
| 09.45 - 10.00 |
| 5A-S21-4 |
TO BE ANNOUNCED |
| |
To be announced |
| 10.00 - 10.15 |
| 5A-S21-5 |
EX VIVO MODULATION OF THE ALLOREACTIVITY OF PRIMARY NK CELLS |
| |
A. Seltsam, R. Blasczyk, C. Figueiredo (Hannover Medical School,
Hannover, Germany) |
| 10.15 - 10.30 |
| 5A-S21-6 |
A PRELIMINARY STUDY ON THE BIOLOGICAL CHARACTERS AND FUNCTION OF
EXOSOMES DERIVED FROM DENDRITIC CELLS |
| |
H. Fan, Y. Ren (Shanghai Blood Center, Shanghai, China) |
| |
|
| 08.30 - 10.30 |
Auditorium A |
| SESSION 22: |
Consensus and Controversial in Blood Transfusion |
| Chairs: |
F. Decary, J. Cid |
| 08.30 - 08.55 |
| 5A-S22-1 |
CONSENSUS CONFERENCE ON PATHOGEN INACTIVATION |
| |
M. Blajchmann (McMaster University, Hamilton, Canada) |
| 08.55 - 09.20 |
| 5A-S22-2 |
PLATELET RICH PLASMA (PRP) AND PLATELET DERIVATIVES FOR TOPICAL THERAPY.
WHAT IS TRUE? |
| |
P. Borzini, L. Mazzucco (Ospedale SS Antonio e Biagio, Alessandria Al,
Italy) |
| 09.20 - 09.45 |
| 5A-S22-3 |
STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE
ULTRAVIOLET LIGHT |
| |
H. Mohr, U. Gravemann, A. Bayer, F. Tolksdorf, W.H. Walker, T.H. Müller
(Blood Center of the German Red Cross, Springe, Germany) |
| 09.45 - 10.00 |
|
| 5A-S22-4 |
NET COST IMPACT OF IMPLEMENTATION OF PHOTOCHEMICAL PATHOGEN INACTIVATION
(INTERCEPT BLOOD SYSTEM™ FOR PLATELETS) FOR PREPARATION OF PLATELET
COMPONENTS |
| |
J.P. Cazenave, I. Metzger, J. Dréno, H. Isola, N. Léon, A. Chicoye
(Établissement Français du Sang-Alsace, Strasbourg, France) |
| 10.00 - 10.15 |
| 5A-S22-5 |
SURVEILLANCE STUDY OF THE TRANSFUSION EFFICIENCY AFTER TRANSFUSIONS OF
APHERESIS PLATELET CONCENTRATES AND POOLED PLATELET CONCENTRATES |
| |
J. Vasse, R. Tardivel, S. Gaucheron, G. Andreu, G. Semana (EFS Bretagne,
Rennes, France) |
| 10.15 - 10.30 |
|
| 5A-S22-6 |
COMPARATIVE STUDY OF FIBRIN SEALANT PREPARED FROM CONVENTIONAL AND
INTERCEPT BLOOD SYSTEM ™ PLASMA USING THE CRYOSEAL® FS-SYSTEM |
| |
V. Kumar, L. Pinkoski, J. Chapman, L. Corash (Thermogenesis Corp.,
Rancho Cordova, United States of America) |
| |
|
| 08.30 - 10.20 |
Paris |
| SESSION 23: |
Foetal Genotyping in the Practice |
| Chairs: |
A. Brand, N. Nogues |
| 08.30 - 08.55 |
| 5A-S23-1 |
FETAL GENOTYPING BEYOND THE RH(D) ANTIGEN |
| |
K. Finning (International Blood Group Reference, Bristol, United
Kingdom) |
| 08.55 - 09.20 |
| 5A-S23-2 |
RHD FETAL GENOTYPING AS A ROUTINE TOOL IN THE PREVENTION OF THE
HAEMOLYTIC DISEASE OF THE NEWBORN. THE DUTCH EXPERIENCE |
| |
E. van der Schoot (Sanquin, Amsterdam, The Netherlands) |
| 09.20 - 09.50 |
| 5A-S23-3 |
RHD FETAL GENOTYPING AS A ROUTINE TOOL IN THE PREVENTION OF THE
HAEMOLYTIC DISEASE OF THE NEWBORN. THE FRENCH EXPERIENCE |
| |
Y. Colin (INSERM/INTS, U665, Paris, France) |
| 09.50 - 10.05 |
| 5A-S23-4 |
ROUTINE CLINICAL PRACTICE OF FOETAL RHD GENOTYPING USING MATERNAL PLASMA
IN BELGIUM: A FOUR-YEAR EXPERIENCE |
| |
J.M. Minon, J.P. Schaaps, J.M. Senterre, J.M. Foidart (CHR de la
Citadelle, Liège, Belgium) |
| 10.05 - 10.20 |
|
| 5A-S23-5 |
THE GERMAN FEASIBILITY STUDY ON NON-INVASIVE DETERMINATION OF THE FETAL
D-STATUS FROM MATERNAL PLASMA FOR DECISION MAKING ON RH-PROPHYLAXIS |
| |
J. Legler, S. Damme, S. Müller (University Medicine Göttingen,
Göttingen, Germany) |
| |
|
| 11.00 - 11.45 |
Auditorium A |
| |
PLENARY SESSION 3 |
| Chairs: |
L. Hernandez-Nieto, A. Al Amiri |
| 11.00 - 11.45 |
| 5B-PL3-1 |
GOVERNMENT, MEDIA AND DECISION MAKING IN TRANSFUSION MEDICINE |
| |
J.P. AuBuchon (Dartmouth-Hitchcock Medical Center, Lebanon, Nh, USA)
|
| |
|
| 11.45 – 12.45 |
Auditorium A |
| |
CLOSING SESSION |
| Chairs: |
M. Algora, J.C. Faber |
| 5B-PL4-1 |
BLOOD BANKING IN AN EU WITHOUT BORDERS |
| |
P.F.W. Strengers (Sanguin, Amsterdam, The Netherlands) |
| 5B-PL4-2 |
CLOSING REMARKS AND CLOSING CEREMONY |
Abstracts & posters
